Shiozaki A, Arai T, Izumi R, Niiya K, Sakuragawa N
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Japan.
Thromb Res. 1993 May 1;70(3):211-6. doi: 10.1016/0049-3848(93)90127-a.
A patient with antithrombin III deficiency developed deep vein thrombosis during her first pregnancy. Her pregnancy and delivery were successfully treated with simultaneous administration of antithrombin III concentrates and low molecular weight heparin. She delivered a 2,412g girl at 39 weeks' gestation. The baby was administered with antithrombin III concentrates as prophylaxis for neonatal arterial and venous thrombosis because the antithrombin III level was extremely low to be 2%. Her second pregnancy was uneventful at 38 weeks' gestation, and she was treated with administration of antithrombin III concentrates prophylactically. She delivered a 3,256g boy at 42 weeks' gestation without any complications. The antithrombin III level of the second baby was normal. These results showed that in a neonate with congenital antithrombin III deficiency the antithrombin III concentrates would be administered to prevent neonatal arterial and venous thrombosis.
一名抗凝血酶III缺乏的患者在首次怀孕时发生了深静脉血栓形成。通过同时给予抗凝血酶III浓缩物和低分子量肝素,她的妊娠和分娩得到了成功治疗。她在妊娠39周时产下一名体重2412克的女婴。由于抗凝血酶III水平极低,仅为2%,该婴儿接受了抗凝血酶III浓缩物治疗以预防新生儿动静脉血栓形成。她的第二次妊娠在妊娠38周时顺利进行,她接受了预防性抗凝血酶III浓缩物治疗。她在妊娠42周时产下一名体重3256克的男婴,没有任何并发症。第二个婴儿的抗凝血酶III水平正常。这些结果表明,对于先天性抗凝血酶III缺乏的新生儿,应给予抗凝血酶III浓缩物以预防新生儿动静脉血栓形成。